AbbVie
The Director, Computational HitGen / LeadGen Team Lead at AbbVie will lead the computational HitGen/LeadGen team, driving AI-native drug discovery for small molecule programs. Reporting to the Head of Computational Drug Discovery, the role focuses on developing cutting‑edge computational methods, guiding cross‑functional collaborations, and advancing the small‑molecule pipeline through strategic leadership and mentorship.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
Right around the average for this role
Computational Chemistry Scientist
Roche
Cheminformatics/Computational Chemistry Scientist
Eli Lilly and Company
Computational Theoretical Chemist II
1910
Computational Theoretical Chemist III
1910
Small Molecule Computational Scientist
Boltz
Senior Scientist: Cheminformatics & Computational Chemistry
Global Channel Management